XENETIC BIOSCIENCES, INC. Stock Issued During Period, Shares, New Issues
XENETIC BIOSCIENCES, INC. (XBIO) reported Stock Issued During Period, Shares, New Issues of 850.00 thousand shares for the 0-month period ending 2022-10-12, per its 10-Q filed 2022-11-09.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2022-11-09
- 2022-10-12: Stock Issued During Period, Shares, New Issues 0 month 850.00K shares.
- 2014-01-23: Stock Issued During Period, Shares, New Issues 0 month 132.55M shares; Stock Issued During Period, Shares, New Issues 132.55M shares.
| Period end | Stock Issued During Period, Shares, New Issues 0 month | Stock Issued During Period, Shares, New Issues |
|---|---|---|
| 2022-10-12 | 850.00K shares 10-Q · filed 2022-11-09 | |
| 2014-01-23 | 132.55M shares 10-Q · filed 2014-05-20 | 132.55M shares 10-Q · filed 2014-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |